ISSN 0303-5212
 
2023, Vol: 48, Issue: 2
48 / 2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Author certificate
Bank Reciept

Original Research 
RMJ. 2023; 48(3): 659-661


Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention

Zainab R. Lafta, Tahseen R. M.

Abstract
Objective: To evaluate the effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention
Methodology: Thia quasi-experimental study was carried out at Al- Nasiriyah Heart Center in Thi-Qar Governorate from 19th of May to 25th of October 2022. A non-probability (purposive) sample of 100 patients were divided into two groups; 50 patients as study and 50 as controls. We used General Medication Adherence Scale, which is composed of 11 items. Validity and reliability of the instrument are determined through a pilot study. Data were analyzed through SPSS version 24.
Results: Patients in the study group showed poor level of adherence during the pre-test (84%) while they showed good and high levels of adherence during the post-test (good= 50% and high=34%).
Conclusion: The instructional program was influential in enhancing patient's adherence regarding clopidogrel therapy post percutaneous coronary intervention

Key words: Percutaneous coronary intervention, clopidogrel, adherence.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Zainab R. Lafta
Articles by Tahseen R. M
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Lafta ZR, M TR. Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention. RMJ. 2023; 48(3): 659-661.

Web Style

Lafta ZR, M TR. Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention. https://www.rmj.org.pk/?mno=145857 [Access: September 03, 2023].

AMA (American Medical Association) Style

Lafta ZR, M TR. Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention. RMJ. 2023; 48(3): 659-661.


Vancouver/ICMJE Style

Lafta ZR, M TR. Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention. RMJ. (2023), [cited September 03, 2023]; 48(3): 659-661.


Harvard Style

Lafta, Z. R. & M, . T. R. (2023) Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention. RMJ, 48 (3), 659-661.


Turabian Style

Lafta, Zainab R., and Tahseen R. M. 2023. Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention. Rawal Medical Journal, 48 (3), 659-661.


Chicago Style

Lafta, Zainab R., and Tahseen R. M. "Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention." Rawal Medical Journal 48 (2023), 659-661.


MLA (The Modern Language Association) Style

Lafta, Zainab R., and Tahseen R. M. "Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention." Rawal Medical Journal 48.3 (2023), 659-661. Print.


APA (American Psychological Association) Style

Lafta, Z. R. & M, . T. R. (2023) Effectiveness of an instructional program on patient's adherence about clopidogrel therapy post percutaneous coronary intervention. Rawal Medical Journal, 48 (3), 659-661.


Author LoginReviewer LoginEditorial PoliciesConflict of Interest PolicyPlagiarism PolicyAdvertising Policy

About Rawal Medical Journal

Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information